
How Private Equity Killed the American Dream
Twelve million people in the US now work for companies owned by private equity, Greenwell writes, or about 8 percent of the total employed population. Her book focuses on the stories of four of these individuals, including a Toys 'R' Us supervisor who loses the best job she ever had and a Wyoming doctor who watches his rural hospital cut essential services. Their collective experiences are a damning account of how innovation is being replaced by financial engineering and the ways that shift is being paid for by everyone except those at the top.
In a review of Bad Company for Bloomberg, a longtime private equity executive accused Greenwell of seeking out sad stories with inevitably 'sad endings.' But the characters Greenwell selected don't just sit back and watch as private equity devastates their communities. The book is a portrait of not only how the American dream is being eroded but also the creative tactics people are using to fight back.
Greenwell spoke to WIRED late last month about what private equity is and isn't, how it has transformed different industries, and what workers are doing to reclaim their power.
This interview has been edited for clarity and length.
WIRED: What is private equity? How is the business model different from, say, venture capital?
Megan Greenwell: People confuse private equity and venture capital all the time, but it's totally reasonable that normal people don't understand the difference. Basically, the easiest way to explain the difference is that venture capital firms invest money, usually in startups. They're essentially taking a stake in the company and expecting some sort of returns over time. They're also generally playing a significantly longer game than private equity.
But the way private equity works, especially with leveraged buyouts, which is what I focus on in the book, is they're buying companies outright. In venture capital, you put your money in, you're entrusting it to a CEO, and you probably have a board seat. But in the leveraged buyout model, the private equity firm really is the owner and controlling decider of the portfolio company.
How do private equity firms define success? What kinds of companies or businesses are attractive to them?
In venture capital, VCs are evaluating whether to make a deal based solely on whether they think that company is going to become successful. They are looking for unicorns. Is this company going to be the next Uber? Private equity is looking to make money off of companies in ways that don't actually require the company itself to make money. That is like the biggest thing.
So it's less of a gamble.
It is very hard for private equity firms to lose money on deals. They're getting a 2 percent management fee, even if they're running the company into the ground. They're also able to pull off all these tricks, like selling off the company's real estate and then charging the company rent on the same land it used to own. When private equity firms take out loans to buy companies, the debt from those loans is assigned not to the private equity firm but to the portfolio company.
And so what you end up getting is that private equity is really attracted to companies where you don't have to play the long game. In fact, you don't want to play the long game, which means that you have no interest in doing the hard, slow work of improving a company's fundamentals. It is just not about improving the company at all. It is about, how do we extract money?
How did we get to this point where private equity is now taking over relatively large and diverse swaths of the economy, including veterinary clinics, brick-and-mortar retail stores, and all sorts of other businesses. What was the promise of this model?
Private equity started pretty small in the 1960s with what were then called 'bootstrap deals,' essentially acquisitions of small, family-run companies that maybe showed promise for expansion but didn't have the capital necessary to grow. So in some ways it was more like venture capital, although it targeted established companies and not brand-new startups. This idea of growth at all costs then just expanded and expanded and expanded and started swallowing more and more and more things.
When did private equity start to peak?
There was a huge expansion of private equity in the 2010s for the same reason that venture capital exploded: There was a lot of cheap money out there, and cheap money is great for investors. We've seen private equity explore more industries over time, and usually that's because some policy change or broader economic trend all of a sudden makes a certain sector look like fertile ground for them.
What are some of the strategies that workers have used to fight back against private equity firms? Have they been successful?
What was interesting to me was not prescribing solutions but talking about what people are doing. The four characters in my book are all trying to do something about this in very different ways, and those range from fighting for regulation, to just going head-to-head directly with the private equity firm that upended their own life, to really trying to reinvent their industries from the ground up, which is something that is especially inspiring to me.
Do you have one that has stuck with you more than the others?
One example that I'll talk about from the book is from the Toys 'R' Us section. Public pension funds are a huge source of capital for private equity firms, and they typically have worker representatives on their boards. So if they're representing teachers and nurses and firefighters, there will be one or more people working in those professions serving on the pension fund board.
Toys 'R' Us workers had this very smart idea that those folks would be more likely to be sympathetic to their cause than a bunch of billionaires would. So they started going around the country, standing in front of these pension fund boards and saying 'here is how these private equity firms that you invest in have blown up our lives,' talking in really specific detail about things like how they couldn't find jobs and were worried about feeding their families. The protagonist of that section of my book tells a story about how the members of one board just started peppering her with questions after she spoke in front of them.
Some people claim that private equity firms are the primary culprit behind broad economic problems such as income inequality and the housing crisis. Are they putting the blame in the right place?
I think by putting all of the blame on them, you end up undermining the criticisms about private equity firms that are more truthful. This is something that I thought really hard about how to do in the book, because I do think it's a mistake actually, but also strategically for people who want to see this system change, to attribute too much to them.
Right.
The first section of the book tells the story of how the four industries I write about—housing, hospitals, retail, and local media—got themselves into trouble in the first place. In all of those cases, the problems are so fundamental. And in many of those cases, the earlier business decisions were so bone-headed that they essentially opened the door and invited private equity to walk right in. I do think private equity is a villain in terms of the way they have taken advantage of these industries for their own gain, but it is absolutely true that they did not cause the problems.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Performance Food Group Company to Host Webcast of Fourth-Quarter Fiscal 2025 Results
RICHMOND, Va., July 30, 2025--(BUSINESS WIRE)--Performance Food Group Company (PFG) (NYSE:PFGC) will host a live audio webcast at 9 a.m. ET Wednesday, August 13, 2025, to discuss fourth-quarter fiscal 2025 financial results. PFG will issue a news release with those results at approximately 7 a.m. ET that same day. George Holm, PFG Chairman & Chief Executive Officer, Patrick Hatcher, Executive Vice President & Chief Financial Officer, and Scott McPherson, President & Chief Operating Officer will discuss the company's fourth-quarter fiscal 2025 results and answer questions from the investment community and news media. The webcast will be available in listen-only mode at Pre-event registration is necessary. An archived copy of the webcast will be available later that same day. About Performance Food Group Company Performance Food Group is an industry leader and one of the largest food and foodservice distribution companies in North America with more than 150 locations. Founded and headquartered in Richmond, Virginia, PFG and our family of companies market and deliver quality food and related products to over 300,000 locations including independent and chain restaurants; businesses, schools and healthcare facilities; vending and office coffee service distributors; and big box retailers, theaters and convenience stores. PFG's success as a Fortune 100 company is achieved through our approximately 43,000 dedicated associates committed to building strong relationships with the valued customers, suppliers and communities we serve. To learn more about PFG, visit View source version on Contacts Investors: Bill MarshallSr. Vice President, Investor Relations(804) Media: Scott GoldenDirector, Communications & Engagement(804) 484-7999mediarelations@
Yahoo
18 minutes ago
- Yahoo
Mars Opens New $240M Nature's Bakery Facility in Salt Lake City
Mars is officially opening its new $240M manufacturing facility for Nature's Bakery in Salt Lake City, Utah. The new site will create more than 230 new jobs and unlock the ability to produce more than 1 billion bars each year. In addition to the $6B Mars invested in the U.S. in the last five years, Mars announced yesterday a $2B commitment to U.S. manufacturing through 2026 PASADENA, Calif., July 30, 2025 /PRNewswire/ -- Nature's Bakery, beloved for its soft-baked snack bars and part of the Mars, Incorporated family of brands, is celebrating the opening of its new state-of-the-art baking facility today in Salt Lake City, Utah. The $240 million investment marks a significant milestone in the brand's ongoing expansion and commitment to delivering wholesome snacks to families across the U.S. The 339,000+ square-foot site gives Nature's Bakery the space to grow, with the ability to produce more than 1 billion bars each year. It also brings more than 230 new jobs to the region, supporting the local community while helping meet the rising demand for Nature's Bakery products from families nationwide. "The biggest step we can take to meet our growth goals is making more of the snacks people love, and this new baking facility helps us do exactly that," said Steve Gardiner, CEO of Nature's Bakery. "It gives us the space to grow today and tomorrow, while letting us bake even more efficiently and with even higher quality. Most importantly, it allows us to keep delivering wholesome, feel-good snacks to more families across the country, wherever and whenever they need them." Mars acquired Nature's Bakery in March 2021, and since then, the brand is on pace to more than double its size from 2020 to now. "The snacking category continues to grow in importance in the U.S. and as consumers' tastes and preferences evolve, and at Mars, we're focused on accelerating innovation that will shape the future of snacking," said Blas Maquivar, Global President of Health & Wellness Division. "The Mars local investment in the new Salt Lake City-based Nature's Bakery facility will enable us to expand the reach of our health and wellness brand, strengthening our focus and introducing more consumers to our better-for-you offering." Strategically located in Salt Lake City's Mountain West neighborhood, the new site helps improve national distribution and reduces delivery distances to retailers. The new bakery facility is LEED Silver-certified and is expected to lower trucking-related CO₂ emissions by an estimated 5,700 tons annually. The facility also features smart automation, including innovative systems for ingredient delivery, mixing, and cooling. These advancements allow Nature's Bakery to not only enhance food safety and consistency but also evolve many manual roles into higher-skilled positions, creating greater opportunities for long-term career development for associates. "Manufacturing is one of Utah's key industries — driving job creation, strengthening supply chains and fueling long-term growth," said Jefferson Moss, executive director of the Governor's Office of Economic Opportunity. "Nature's Bakery's new facility is exactly the kind of high-impact investment that positions Utah for continued success. We're proud to welcome the company as it expands in Salt Lake City, bringing quality jobs and reinforcing our state's reputation as a top destination for advanced manufacturing." "Nature's Bakery has brought with them not only economic opportunity but also care for our community—even before a single production line has gone live," said Salt Lake City Mayor Erin Mendenhall. "From supporting local schools to showing up at events across the city, they've embraced our residents with generosity and heart. We're proud to welcome them to Salt Lake City." In the United States, Mars has a presence in 49 states, employs over 70,000 Associates and operates 38 factories in addition to veterinary clinics, labs and 16 global and regional offices. ABOUT MARS, INCORPORATED Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As an approximately $55bn family-owned business, our diverse and expanding portfolio of leading pet care products and veterinary services support pets all around the world and our quality snacking and food products delight millions of people every day. We produce some of the world's best-loved brands including Royal Canin®, PEDIGREE®, WHISKAS®, CESAR®, DOVE®, EXTRA®, M&M'S®, SNICKERS® and BEN'S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles — Quality, Responsibility, Mutuality, Efficiency and Freedom — inspire our 150,000 Associates to act every day to help create a better world for people, pets and the planet. For more information about Mars, please visit Join us on Facebook, Instagram, LinkedIn and YouTube. ABOUT NATURE'S BAKERY Nature's Bakery believes simple, wholesome snacks are the best fuel for active, joyful lives. Founded in 2011, they soft bake the goodness of real, wholesome ingredients like sun-ripened fruit and hearty whole grains into snacks that are plant-based, nut-free, dairy-free, and non-GMO Project Verified. Thoughtfully baked to make better-for-you snacking a deliciously easy choice that appeals to the whole family, Nature's Bakery products include Whole Wheat Fig Bars, Gluten Free Fig Bars, Fig Bar Minis, Oatmeal Crumble Bars, Brownie Bars, and Hearty Bars. Nature's Bakery products are sold nationally at 100,000 stores, including Target, Walmart, and Costco and can also be purchased directly at the Nature's Bakery website and through Amazon. For more information about Nature's Bakery, please visit or follow along on Instagram, TikTok and Facebook. Media Contact: Mary Jane McComiskey View original content to download multimedia: SOURCE Mars, Incorporated Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
BioStem Technologies to Host Second Quarter 2025 Financial Results Conference Call on August 14, 2025
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived products for advanced wound care, announces it will release its second quarter 2025 financial results on Thursday, August 14, 2025, and host a conference call and webcast at 4:30 PM ET. The webcast will feature a review of second quarter results and an update on the Company's Form 10 filing and Nasdaq uplisting, led by CEO Jason Matuszewski and CFO Michael Fortunato. To register for the event, please click HERE. Conference Call & Webcast Information: Conference ID: 9695874 North America Toll-Free: (800) 715-9871 International Toll: +1 (646) 307-1963 Webcast Link: Join BioStem's Distribution List & Social Media: To follow the latest developments at BioStem, sign up for the Company's email distribution list HERE, and follow us on X and LinkedIn. About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for advanced wound care. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in advanced wound care, focused on maintaining growth factors and preserving tissue structure. BioStem's quality management systems and standard operating procedures are accredited by the American Association of Tissue Banks ('AATB') and adhere to Good Tissue Practices (cGTP) and Good Manufacturing Processes ('cGMP'). Our portfolio of quality brands includes AmnioWrap2™, VENDAJE®, VENDAJE AC®, VENDAJE OPTIC®, American Amnion™ and American Amnion™ AC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida. For more information visit Forward-Looking Statements: Except for statements of historical fact, this release also contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts of future events. Forward-looking statements may be identified using words such as 'forecast,' 'intend,' 'seek,' 'target,' 'anticipate,' 'believe,' 'expect,' 'estimate', 'plan,' 'outlook,' 'project,' and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements with respect to the operations of the Company, strategies, prospects, and other aspects of the business of the Company are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from expectations expressed or implied by such forward-looking statements. These factors include, but are not limited to: (1) the impact of any changes to the reimbursement levels for the Company's products; (2) the Company faces significant and continuing competition, which could adversely affect its business, results of operations and financial condition; (3) rapid technological change could cause the Company's products to become obsolete and if the Company does not enhance its product offerings through its research and development efforts, it may be unable to effectively compete; (4) to be commercially successful, the Company must convince physicians that its products are safe and effective alternatives to existing treatments and that its products should be used in their procedures; (5) the Company's ability to raise funds to expand its business; (6) the Company has incurred significant losses since inception and may incur losses in the future; (7) changes in applicable laws or regulations; (8) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; (9) the Company's ability to maintain production of its products in sufficient quantities to meet demand. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Contact BioStem Technologies, Inc.: BioStem Technologies, HoldsworthDirector of Investor Relations E-Mail: adam@ Phone: 917-497-9287 Or Gilmartin GroupPhilip Trip Taylor, PrincipalE-Mail: philip@ 415-937-5406Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten